Satsuma Pharmaceuticals, Inc.
USD1.10
+0.00 (+0.00%)
CEO
John A. Kollins MBA
IPO Date
2019-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.11
Prev. Close
$1.10
Day Low
$1.10
Day High
$1.10
52W Low
$0.59
52W High
$8.08
Market Cap
$0.04B
Volume
1.83M
| -2.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 52.6% | -58.8% | -0.03 | 9.17 | -1.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 66.3% | -22.6% | -0.11 | 14.40 | -4.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 60.6% | -115.1% | -0.41 | 2.75 | -9.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 95.2% | -260.7% | -0.02 | 1.13 | -22.2 |
| -0.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -21.7% | -19.8% | 0.00 | 10.15 | -3.2 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -22.4% | -20.1% | 0.00 | 9.18 | -2.0 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -17.8% | -16.5% | 0.01 | 12.77 | -1.9 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -15.3% | -14.1% | 0.01 | 11.76 | -2.3 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -11.5% | -10.9% | 0.01 | 16.60 | -2.7 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -9.3% | -8.7% | 0.02 | 16.66 | -4.7 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -7.6% | -7.3% | 0.02 | 25.50 | -3.1 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | -17.3% | -15.4% | 0.04 | 9.17 | -1.6 |